| Labcorp

November 17, 2023

Performance Assessment of the Labcorp® Plasma Complete™ Test for Comprehensive Genomic Profiling of Solid Tumors Through Liquid Biopsy

Labcorp® Plasma Complete™ is a comprehensive next generation sequencing (NGS), cell free DNA profiling test that identifies clinically relevant variants in advanced and metastatic solid tumors across 521 genes as well as microsatellite instability (MSI).

November 16, 2023

Tigerlily Foundation and Labcorp Launch I AM INCLUDED Framework to Increase Clinical Trial Diversity, Accelerate Delivery of Innovative Cancer Treatments

BURLINGTON, N.C. and WASHINGTON , Nov. 16, 2023 /PRNewswire/ -- Today, the Tigerlily Foundation (Tigerlily), a leading breast cancer patient advocacy organization, and Labcorp , a global leader of innovative and comprehensive laboratory services, announced the launch of I AM INCLUDED , a

Labcorp solutions: How data-driven excellence enhances patient health

Learn how Labcorp’s world-class diagnostics and insight-driven analytics provides:

Succeeding in quality measures leveraging the use of lab data

Distinguished panelists from CHESS Health Solutions, Imperium Health Management and Labcorp detail how national data can help you close lab-based care gaps and succeed in quality measures. In this presentation, you’ll discover how:

November 8, 2023

Ovia Health Unveils New Fertility and Family Building Benefit

Expanded offering adds inclusive end-to end support for pre-conception, adoption and surrogacy while removing barriers to equitable care access BOSTON , Nov. 8, 2023 /PRNewswire/ -- Ovia Health by Labcorp (Ovia) today announced it will offer a first-of-its-kind Fertility and Family Building Benefit

November 6, 2023

A daughter's dedication to improving Alzheimer's care with advanced testing

Alzheimer’s disease can be a devastating illness—not just for the patients diagnosed with the disease, but for the caretakers in their life as well.

November 17, 2023

Laboratory Automation of PGDx elio™ Tissue Complete on the Biomek NGeniuS System Enables Accurate and Reproducible Comprehensive Genomic Profiling

PGDx elio™ Tissue Complete (ETC) is a comprehensive tumor profiling next generation sequencing (NGS) kitted solution. NGS-based solutions often involve complex protocols with multiple touchpoints that might benefit from automation.

Managing Your Health

Diseases & Specialties

Treatment Methods & Product Testing

Lab Disciplines & Services